These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 2860723)
1. Positron emission tomography: human brain function and biochemistry. Phelps ME; Mazziotta JC Science; 1985 May; 228(4701):799-809. PubMed ID: 2860723 [TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of regional cerebral glucose metabolism. Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomographic studies of local cerebral glucose metabolism in humans in physiological and pathophysiological conditions. Reivich M; Alavi A Adv Metab Disord; 1983; 10():135-76. PubMed ID: 6364712 [No Abstract] [Full Text] [Related]
10. Functional studies in brain and heart with positron emission tomography. Wieler H; Herzog H; Patton DD; Schmid A; Rota E; Feinendegen LE Med Prog Technol; 1986; 11(2):73-106. PubMed ID: 3018467 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in the investigation of central nervous system disorders. Jamieson D; Alavi A; Jolles P; Chawluk J; Reivich M Radiol Clin North Am; 1988 Sep; 26(5):1075-88. PubMed ID: 3047777 [TBL] [Abstract][Full Text] [Related]
12. Brain metabolism in mitochondrial encephalomyopathy: a PET study. De Volder A; Ghilain S; de Barsy T; Goffinet AM J Comput Assist Tomogr; 1988; 12(5):854-7. PubMed ID: 3262636 [TBL] [Abstract][Full Text] [Related]
13. Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more? Azari NP; Pietrini P J Neurol; 1995 Jan; 242(2):112-4. PubMed ID: 7707087 [No Abstract] [Full Text] [Related]
14. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism. Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724 [No Abstract] [Full Text] [Related]
15. Potential of NMR and PET for determining tumor metabolism. Miraldi F Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1033-9. PubMed ID: 3528086 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects. Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919 [No Abstract] [Full Text] [Related]
17. Introduction to imaging brain tumor metabolism with positron emission tomography (PET). Conti PS Cancer Invest; 1995; 13(2):244-59. PubMed ID: 7874578 [TBL] [Abstract][Full Text] [Related]
18. Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI-PET scanning. Newberg AB; Wang J; Rao H; Swanson RL; Wintering N; Karp JS; Alavi A; Greenberg JH; Detre JA Neuroimage; 2005 Nov; 28(2):500-6. PubMed ID: 16084114 [TBL] [Abstract][Full Text] [Related]
19. [Functional brain study by radionuclide neuroimaging]. Uemura K No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632 [No Abstract] [Full Text] [Related]
20. [Comparison of the different methods to calculate cerebral glucose utilization using F-18 FDG and PET]. Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Miyake Y; Uehara S; Yoshimura A; Masuda K Kaku Igaku; 1989 Mar; 26(3):459-63. PubMed ID: 2787439 [No Abstract] [Full Text] [Related] [Next] [New Search]